Latest stories on CING
Cingulate CEO Discusses CTx-1301 FDA Regulatory Progress
TipRanks58 · neutralproduct/pr
Cingulate Inc. (CINGW) files 8-K
SEC 8-K50 · neutralgeneral
Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King
GlobeNewswire55 · neutralproduct/pr
Cingulate Inc. (CINGW) files 8-K
SEC 8-K50 · neutralgeneral
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Business Insider56 · neutralproduct/pr
Cingulate price target lowered to $9 from $10 at Roth Capital
The Fly38 · neutralanalyst
Cingulate reports Q2 results
Seeking Alpha50 · neutralearnings
Cingulate Inc. (CINGW) files 8-K
SEC 8-K50 · neutralgeneral
Cingulate Publishes Peer Reviewed Data On Ctx 1301 Pharmacokinetic Profile
The Fly59 · neutralproduct/pr
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
Business Insider63 · neutralproduct/pr
Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
StockTitan63 · neutralproduct/pr
Cingulate Inc. (CINGW) files 8-K
SEC 8-K50 · neutralgeneral
Cingulate Inc. (CINGW) files 8-K
SEC 8-K50 · neutralgeneral
Cingulate added to Russell 3000E Index
Seeking Alpha63 · neutralgeneral
Cingulate Inc. (CINGW) files 8-K
SEC 8-K50 · neutralgeneral
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E® | CING Stock News
StockTitan63 · neutralgeneral
Ciena, Cisco, Nokia among group that may benefit from Nvidia telecom project: Needham
Seeking Alpha67 · bullishproduct/pr
Cingulate Gains Key U.S. Patent for Lead ADHD Drug
TipRanks67 · bullishproduct/pr
Cingulate Inc. (CINGW) files 8-K
SEC 8-K50 · neutralgeneral
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301 | CING Stock News
StockTitan63 · neutralproduct/pr
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26 | CING Stock News
StockTitan34 · bearishanalyst
Cingulate Receives Complete Response Letter from FDA for CTx-1301 | CING Stock News
StockTitan58 · neutralproduct/pr